JDD Special Focus

Acne Podcast Episodes

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Podcast Episodes

Ask the Investigator: Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient

 

JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled “Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients” published in the June 2016 edition of the Journal of Drugs of Dermatology. Want a refresher on the use of OCPs in Acne?

Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Sponsored

Featured Editorials

Virtual Exams No Substitute for In-Person Care of Acne and Rosacea

Some dermatologists may be surprised to hear that the concept of teledermatology originated 25 years ago, and has slowly increased in usage, primarily for the purpose of providing care to those in underserved areas.1 The challenges created by the COVID19 pandemic has rapidly accelerated both interest and usage of telemedicine by dermatologists, with the American Academy of Dermatology and other dedicated groups responding quickly to provide guidance on how to integrate teledermatology into real-world dermatology practice effectively, and hopefully with avoidance of technical, medicolegal, and financial pitfalls.2

 

Read Now

Sponsored

Featured Supplement

Androgens, Androgen Receptors, and the Skin

Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum production, faulty keratinization, and overgrowth of C. acnes—androgen excess has been the most elusive therapeutic target. Oral contraceptive pills (OCPs) have direct effect on circulating hormones, but their potential use is limited to a subset of women. As such, a sizable portion of the population affected by acne vulgaris cannot even consider treatment with OCPs. While these systemic agents are generally associated with a low risk profile and have a history of safe and effective use, they are not entirely risk-free. Indirect androgen modulation has become increasingly popular. Again, while generally safe and effective, this systemic treatment is not without risks and contraindications and it is also limited to a subset of female patients.

Read Now

Dermatology News

Journal of Drugs in Dermatology JDD Article About A Systematic Review: Application of Rice Products for Hair GrowthAlopeciaFeatured ArticlesLatest NewsThe Latest
August 12, 2025

A Systematic Review: Application of Rice Products for Hair Growth

Rice Bran Reimagined: A New Frontier in Hair Health Could this ancient grain extract be the next go-to for patients battling
Journal of Drugs in Dermatology JDD Article About Efficacy of Low-Dose Spironolactone for Hair Loss in WomenAlopeciaFeatured ArticlesHairLatest NewsThe LatestWomen
August 11, 2025

Efficacy of Low-Dose Spironolactone for Hair Loss in Women

Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Journal of Drugs in Dermatology JDD Article About The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart ReviewAcneFeatured ArticlesLatest NewsThe Latest
August 11, 2025

Unveiling the Future of Acne Care with the Acne Resource Center – Check It Out

Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center  - your new go-to microsite for the very…
Featured ArticlesThe LatestVideo Abstract
August 8, 2025

PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact

Check out our all-new JDD Video Abstract from Christopher G. Bunick, who discusses PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact.